НовостиBenzingaHC Wainwright & Co. Assumes Odyssey Therapeutics at Buy, Announces Price Target of $40 HC Wainwright & Co. Assumes Odyssey Therapeutics at Buy, Announces Price Target of $40 Benzinga 2026.11.06 12:11 (GMT+0) Открыть на Benzinga Другие новости